Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry

Authors:

Abstract
No abstract available
Funding Information
  • National Center for Advancing Translational Sciences
  • National Institutes of Health (HL-R01-108229, UL1TR001105)
  • Boston Scientific Corporation
  • National Heart, Lung, and Blood Institute
  • Abbott Vascular
  • Merck

This publication has 31 references indexed in Scilit: